211 related articles for article (PubMed ID: 27086081)
41. Recent Update on Targeting
Chaudhuri R; Bhattacharya S; Dash J; Bhattacharya S
J Med Chem; 2021 Jan; 64(1):42-70. PubMed ID: 33355454
[TBL] [Abstract][Full Text] [Related]
42. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
Jain AK; Bhattacharya S
Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
[TBL] [Abstract][Full Text] [Related]
43. Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives.
Brito H; Martins AC; Lavrado J; Mendes E; Francisco AP; Santos SA; Ohnmacht SA; Kim NS; Rodrigues CM; Moreira R; Neidle S; Borralho PM; Paulo A
PLoS One; 2015; 10(5):e0126891. PubMed ID: 26024321
[TBL] [Abstract][Full Text] [Related]
44. Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule.
Zorzan E; Elgendy R; Giantin M; Dacasto M; Sissi C
Sci Rep; 2018 Nov; 8(1):17107. PubMed ID: 30459395
[TBL] [Abstract][Full Text] [Related]
45. Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection-Mass Spectrometry.
Flusberg DA; Rizvi NF; Kutilek V; Andrews C; Saradjian P; Chamberlin C; Curran P; Swalm B; Kattar S; Smith GF; Dandliker P; Nickbarg EB; O'Neil J
SLAS Discov; 2019 Feb; 24(2):142-157. PubMed ID: 30204533
[TBL] [Abstract][Full Text] [Related]
46. Spectroscopic and biological studies of phenanthroline compounds: selective recognition of gene-promoter G-quadruplex DNAs preferred over duplex DNA.
Wang L; Wei C
Chem Biodivers; 2013 Jun; 10(6):1154-64. PubMed ID: 23776031
[TBL] [Abstract][Full Text] [Related]
47. Fe
Malina J; Kostrhunova H; Scott P; Brabec V
Chemistry; 2021 Aug; 27(45):11682-11692. PubMed ID: 34048082
[TBL] [Abstract][Full Text] [Related]
48. Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules.
Francisco AP; Paulo A
Curr Med Chem; 2017; 24(42):4873-4904. PubMed ID: 27573064
[TBL] [Abstract][Full Text] [Related]
49. Stable G-Quadruplex Structures of Oncogene Promoters Induce Potassium-Dependent Stops of Thermostable DNA Polymerase.
Chashchina GV; Beniaminov AD; Kaluzhny DN
Biochemistry (Mosc); 2019 May; 84(5):562-569. PubMed ID: 31234770
[TBL] [Abstract][Full Text] [Related]
50. BCL2 G quadruplex-binding small molecules: Current status and prospects for the development of next-generation anticancer therapeutics.
Singh M; Gupta R; Comez L; Paciaroni A; Rani R; Kumar V
Drug Discov Today; 2022 Sep; 27(9):2551-2561. PubMed ID: 35709931
[TBL] [Abstract][Full Text] [Related]
51. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
[TBL] [Abstract][Full Text] [Related]
52. Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex.
Calabrese DR; Chen X; Leon EC; Gaikwad SM; Phyo Z; Hewitt WM; Alden S; Hilimire TA; He F; Michalowski AM; Simmons JK; Saunders LB; Zhang S; Connors D; Walters KJ; Mock BA; Schneekloth JS
Nat Commun; 2018 Oct; 9(1):4229. PubMed ID: 30315240
[TBL] [Abstract][Full Text] [Related]
53. N-cyclic bay-substituted perylene G-quadruplex ligands have selective antiproliferative effects on cancer cells and induce telomere damage.
Casagrande V; Salvati E; Alvino A; Bianco A; Ciammaichella A; D'Angelo C; Ginnari-Satriani L; Serrilli AM; Iachettini S; Leonetti C; Neidle S; Ortaggi G; Porru M; Rizzo A; Franceschin M; Biroccio A
J Med Chem; 2011 Mar; 54(5):1140-56. PubMed ID: 21280624
[TBL] [Abstract][Full Text] [Related]
54. Bisaryldiketene derivatives: A new class of selective ligands for c-myc G-quadruplex DNA.
Peng D; Tan JH; Chen SB; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2010 Dec; 18(23):8235-42. PubMed ID: 21036049
[TBL] [Abstract][Full Text] [Related]
55. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase.
Lemarteleur T; Gomez D; Paterski R; Mandine E; Mailliet P; Riou JF
Biochem Biophys Res Commun; 2004 Oct; 323(3):802-8. PubMed ID: 15381071
[TBL] [Abstract][Full Text] [Related]
56. The Oncogenic Signaling Pathways in
Recagni M; Tassinari M; Doria F; Cimino-Reale G; Zaffaroni N; Freccero M; Folini M; Richter SN
Cells; 2019 Oct; 8(10):. PubMed ID: 31635389
[TBL] [Abstract][Full Text] [Related]
57. Furan based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription.
Agarwal T; Roy S; Chakraborty TK; Maiti S
Bioorg Med Chem Lett; 2010 Aug; 20(15):4346-9. PubMed ID: 20615700
[TBL] [Abstract][Full Text] [Related]
58. Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.
Brown RV; Danford FL; Gokhale V; Hurley LH; Brooks TA
J Biol Chem; 2011 Nov; 286(47):41018-27. PubMed ID: 21956115
[TBL] [Abstract][Full Text] [Related]
59. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
60. Structure-based design of flavone derivatives as c-myc oncogene down-regulators.
Yang H; Zhong HJ; Leung KH; Chan DS; Ma VP; Fu WC; Nanjunda R; Wilson WD; Ma DL; Leung CH
Eur J Pharm Sci; 2013 Jan; 48(1-2):130-41. PubMed ID: 23127826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
